Cargando…

Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas

Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; t...

Descripción completa

Detalles Bibliográficos
Autores principales: Carreón-Burciaga, Ramón G., González-González, Rogelio, Molina-Frechero, Nelly, López-Verdín, Sandra, Pereira-Prado, Vanesa, Bologna-Molina, Ronell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937611/
https://www.ncbi.nlm.nih.gov/pubmed/29850393
http://dx.doi.org/10.1155/2018/9392632
_version_ 1783320657377886208
author Carreón-Burciaga, Ramón G.
González-González, Rogelio
Molina-Frechero, Nelly
López-Verdín, Sandra
Pereira-Prado, Vanesa
Bologna-Molina, Ronell
author_facet Carreón-Burciaga, Ramón G.
González-González, Rogelio
Molina-Frechero, Nelly
López-Verdín, Sandra
Pereira-Prado, Vanesa
Bologna-Molina, Ronell
author_sort Carreón-Burciaga, Ramón G.
collection PubMed
description Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; the expression of E-cadherin and syndecan-1 were evaluated by immunohistochemistry. E-Cadherin and epithelial syndecan-1 were more highly expressed in intraluminal/luminal unicystic ameloblastoma than in mural unicystic ameloblastoma and solid/multicystic ameloblastoma, whereas the stromal expression of syndecan-1 was higher in mural unicystic ameloblastoma and solid/multicystic ameloblastoma. Synchronicity was observed between E-cadherin and epithelial syndecan-1; the expression was correlated with intensity in all cases. There was a strong association between expression and tumor size and recurrence. The evaluation of the expression of E-cadherin and syndecan-1 are important for determining the potential aggressiveness of ameloblastoma variants. Future studies are required to understand how the expression of these markers is related to tumor aggressiveness.
format Online
Article
Text
id pubmed-5937611
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59376112018-05-30 Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas Carreón-Burciaga, Ramón G. González-González, Rogelio Molina-Frechero, Nelly López-Verdín, Sandra Pereira-Prado, Vanesa Bologna-Molina, Ronell Anal Cell Pathol (Amst) Research Article Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; the expression of E-cadherin and syndecan-1 were evaluated by immunohistochemistry. E-Cadherin and epithelial syndecan-1 were more highly expressed in intraluminal/luminal unicystic ameloblastoma than in mural unicystic ameloblastoma and solid/multicystic ameloblastoma, whereas the stromal expression of syndecan-1 was higher in mural unicystic ameloblastoma and solid/multicystic ameloblastoma. Synchronicity was observed between E-cadherin and epithelial syndecan-1; the expression was correlated with intensity in all cases. There was a strong association between expression and tumor size and recurrence. The evaluation of the expression of E-cadherin and syndecan-1 are important for determining the potential aggressiveness of ameloblastoma variants. Future studies are required to understand how the expression of these markers is related to tumor aggressiveness. Hindawi 2018-04-23 /pmc/articles/PMC5937611/ /pubmed/29850393 http://dx.doi.org/10.1155/2018/9392632 Text en Copyright © 2018 Ramón G. Carreón-Burciaga et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Carreón-Burciaga, Ramón G.
González-González, Rogelio
Molina-Frechero, Nelly
López-Verdín, Sandra
Pereira-Prado, Vanesa
Bologna-Molina, Ronell
Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
title Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
title_full Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
title_fullStr Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
title_full_unstemmed Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
title_short Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
title_sort differences in e-cadherin and syndecan-1 expression in different types of ameloblastomas
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937611/
https://www.ncbi.nlm.nih.gov/pubmed/29850393
http://dx.doi.org/10.1155/2018/9392632
work_keys_str_mv AT carreonburciagaramong differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas
AT gonzalezgonzalezrogelio differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas
AT molinafrecheronelly differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas
AT lopezverdinsandra differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas
AT pereirapradovanesa differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas
AT bolognamolinaronell differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas